Multimorbidity and COVID-19 Outcomes in the Emergency Department: Is the Association Mediated by the Severity of the Condition at Admission?
<b>Background/Objectives:</b> Charlson Comorbidity Index (CCI) is one of the most reliable indicators to assess the impact of multimorbidity on COVID-19-related outcomes. Moreover, the patient's clinical conditions are associated with SARS-CoV-2 outcomes. This study aimed to analyze the association between multimorbidity and COVID-19-related outcomes, evaluating whether the National Early Warning Score 2 (NEWS2) mediated these associations. <b>Methods:</b> Data were obtained through the platform "EPICLIN". We analyzed all patients who tested positive for COVID-19 after accessing the emergency department (ED) of San Luigi Gonzaga (Orbassano) and Molinette (Turin) hospitals from 1 March to 30 June 2020. Different outcomes were assessed: non-discharge from the ED, 30-day mortality, ICU admission/death among hospitalized patients, and length of hospitalization among surviving patients. Two subgroups of patients (<65 and 65+ years old) were analyzed using logistic regressions, Cox models, and mediation analyses. <b>Results:</b> There was a greater risk of not being discharged or dying among those who were younger and with CCI ≥ 2. Moreover, the higher the CCI, the longer the length of hospitalization. Considering older subjects, a greater CCI was associated with a higher risk of death. Regarding the mediation analyses, multimorbidity significantly impacted the hospitalization length and not being discharged in the younger population. Instead, in the older population, the NEWS2 played a mediation role. <b>Conclusions:</b> This research showed that multimorbidity is a risk factor for a worse prognosis of COVID-19. Moreover, there was a strong direct effect of CCI on not being discharged, and the NEWS2 was found to act as mediator in the association between multimorbidity and COVID-19-related outcomes.
Authors
- Adriana Boccuzzi (ORCID: https://orcid.org/0000-0002-5789-1997)
- Cinzia Destefanis
- Alessandra Macciotta (ORCID: https://orcid.org/0000-0002-0287-7979)
- Kibrom Teklay Gebru (ORCID: https://orcid.org/0000-0002-9252-7939)
- Alberto Catalano (ORCID: https://orcid.org/0000-0003-2597-2060)
- Valeria Caramello (ORCID: https://orcid.org/0000-0002-6106-0432)
- Carlotta Sacerdote (ORCID: https://orcid.org/0000-0002-8008-5096)
- Fulvio Ricceri (ORCID: https://orcid.org/0000-0001-8749-9737)
- Eva Pagano (ORCID: https://orcid.org/0000-0001-7552-2901)
- Lisa Padroni (ORCID: https://orcid.org/0009-0008-9609-3681)
- Giovannino Ciccone (ORCID: https://orcid.org/0000-0001-7644-9574)
- Lorenzo Milani (ORCID: https://orcid.org/0000-0002-2185-2179)
- Marı́a Teresa Giraudo (ORCID: https://orcid.org/0000-0002-7152-6902)
- Barbara Sodano (ORCID: https://orcid.org/0009-0005-0415-7608)
- Marco Alvich
Institutions
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- Ospedale San Luigi Gonzaga (IT)
- Novamont (Italy) (IT)
- University of Florence (IT)
- University of Turin (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2024-11-26
- DOI
- https://doi.org/10.3390/jcm13237182
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.00